Researchers at Boston University’s Structural Bioinformatics Lab are working with Mercury Computer Systems to develop a system that will make it easier for pharmaceutical companies to develop new ...

SHELTON, CONNECTICUT / ACCESS Newswire / February 12, 2026 / NanoViricides, Inc., a publicly traded company (NYSE ...

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...

On Dec 19, 2025, the US Food and Drug Administration (FDA) announced a major milestone by qualifying total hip bone mineral density (BMD), assessed by dual-energy X-ray absorptiometry, as a surrogate ...

Whether a smartphone battery lasts longer or a new drug can be developed to treat incurable diseases depends on how stably the atoms constituting the material are bonded. The core of 'molecular design ...

Researchers at Texas A&M are pairing a widely used ingredient with advanced medical technology to develop new treatments for ...

Forbes contributors publish independent expert analyses and insights. Gil Press writes about technology, entrepreneurs and innovation. Will AI transform the typical trials and tribulations of drug ...

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...

A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to serve everyone fairly. Only 6% of the clinical trials that backed new ...

Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under ...

Patients living with severe chronic pain don’t only have to manage a debilitating affliction. They also have to deal with the FDA making it harder for them to access potentially life-changing new ...